Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01272570 · ClinicalTrials.gov registry record
Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 58
- Enrollment target
NCT01272570 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 58 participants.
The verdict
NCT01272570 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
The 3 Specific Aims are (1) To determine the prevalence, incidence and severity of oral conditions in postmenopausal early stage breast cancer survivors within the first 18 months of adjuvant Aromatase Inhibitor(AI) therapy, (2) To determine the oral health quality of life among postmenopausal early stage breast cancer survivors who are receiving AI therapy, (3) To determine the utilization of dental care among postmenopausal women receiving AIs with a history of early stage BCa over time. The hypothesis for this pilot study is that AIs negatively impact oral health and oral health quality of life in the setting of breast cancer survivors. Further, we hypothesize that dental visits are underutilized in women with BCa undergoing adjuvant AI therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01272570
The ClinicalTrials.gov registry entry for NCT01272570 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01272570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01272570 about?
NCT01272570 is a clinical study titled "Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors". The 3 Specific Aims are (1) To determine the prevalence, incidence and severity of oral conditions in postmenopausal early stage breast cancer survivors within the first 18 months of adjuvant Aromatase Inhibitor(AI) therapy, (2) To determine the oral health quality of life among postmenopausal early...
What is the current status of trial NCT01272570?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2010-09. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT01272570?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.